Organic growth returned in Q1 2026, but reported sales fell 10% due to currency headwinds. Operating cash flow turned positive for the fourth straight quarter, and site consolidation was completed, with strong outlooks for both Diagnostics and OEM segments.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.